BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22365295)

  • 1. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
    Covey AM; Toro-Pape FW; Thornton RH; Son C; Erinjeri J; Sofocleous CT; Brody LA; Brown KT; Sepkowitz KA; Getrajdman GI
    J Vasc Interv Radiol; 2012 Mar; 23(3):358-62. PubMed ID: 22365295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution.
    Choksi A; Finnegan K; Etezadi V
    Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial.
    Karanlik H; Kurul S; Saip P; Unal ES; Sen F; Disci R; Topuz E
    Am J Surg; 2011 Jul; 202(1):10-5. PubMed ID: 21601826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154 Patients.
    Johnson E; Babb J; Sridhar D
    J Vasc Interv Radiol; 2016 Mar; 27(3):339-43; quiz 344. PubMed ID: 26776446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of radiologically implanted central venous port systems explanted due to complications.
    Teichgräber UK; Kausche S; Nagel SN
    J Vasc Access; 2011; 12(4):306-12. PubMed ID: 21534232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Antibiotics for Reducing Central Line-associated Blood Stream Infection in Children with Totally Implantable Venous Access Devices.
    Akbar SA; Qudsia ZF; Ashraf MN; Tarar MA; Qazi AQ
    J Coll Physicians Surg Pak; 2020 Mar; 30(3):304-308. PubMed ID: 32169141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients.
    Devrim İ; Oruç Y; Demirağ B; Kara A; Düzgöl M; Uslu S; Yaşar N; Aydın Köker S; Töret E; Bayram N; Vergin C
    J Vasc Access; 2018 Jul; 19(4):358-365. PubMed ID: 29926785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
    J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prophylaxis in the placement of totally implanted central venous access ports.
    Scaife CL; Gross ME; Mone MC; Hansen HJ; Litz CL; Nelson ET; Anderson CJ; Wagner G; Gawlick U; Nelson EW
    Am J Surg; 2010 Dec; 200(6):719-22; disussion 722-3. PubMed ID: 21146010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
    Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
    Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
    Wilson GJ; van Noesel MM; Hop WC; van de Ven C
    J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology for venous catheter placement and maintenance.
    Miller DL; O'Grady NP;
    J Vasc Interv Radiol; 2012 Aug; 23(8):997-1007. PubMed ID: 22840801
    [No Abstract]   [Full Text] [Related]  

  • 16. Perioperative antibiotics should be used for placement of implanted central venous ports: A propensity analysis evaluating risk.
    Scaife CL; Mone MC; Bowen ME; Swords DS; Zhang C; Presson AP; Nelson EW
    Am J Surg; 2018 Dec; 216(6):1135-1143. PubMed ID: 30268417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.
    Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I
    Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Totally implantable central venous access devices in patients with cancer. Experience at a private oncology center].
    Cortés-Flores AO; Morgan-Villela G; Juárez-Uzeta EA; Fuentes-Orozco C; Jiménez-Tornero J; González-Ojeda A
    Cir Cir; 2012; 80(5):429-34. PubMed ID: 23351446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Length of Stay Predicts Risk of Early Infection for Hospitalized Patients Undergoing Central Venous Port Placement.
    Tang L; Kim CY; Martin JG; Pabon-Ramos WM; Sag AA; Suhocki PV; Smith TP; Ronald J
    J Vasc Interv Radiol; 2020 Mar; 31(3):454-461. PubMed ID: 32007408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.